Albumedix Revenue and Competitors
Estimated Revenue & Valuation
- Albumedix's estimated annual revenue is currently $21.7M per year.
- Albumedix's estimated revenue per employee is $201,000
Employee Data
- Albumedix has 108 Employees.
- Albumedix grew their employee count by 6% last year.
Albumedix's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Commercial Operations | Reveal Email/Phone |
Albumedix Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $62.9M | 313 | 8% | N/A | N/A |
#2 | $26.5M | 132 | 7% | N/A | N/A |
#3 | $20.5M | 102 | 0% | N/A | N/A |
#4 | $18.3M | 91 | 6% | N/A | N/A |
#5 | $18.7M | 93 | 2% | N/A | N/A |
#6 | $72.2M | 359 | 6% | N/A | N/A |
#7 | $55.3M | 275 | 6% | N/A | N/A |
#8 | $35.8M | 178 | 6% | N/A | N/A |
#9 | $31M | 154 | 4% | N/A | N/A |
#10 | $70.8M | 352 | 5% | N/A | N/A |
What Is Albumedix?
Albumedix helps biopharmaceutical companies improve patient outcomes with a range of albumin-based products and technologies that facilitate the development of superior biotherapeutics.Albumedix develops albumin-based products and technologies for advanced drug and vaccine formulation, extended drug half-life and improved drug delivery. Our products and technologies are used in clinical and marketed drugs and out-licensed to pharmaceutical and biotech companies worldwide. With over 25 years’ experience in the biopharmaceutical industry, we have the scientific, technical and regulatory expertise needed to support companies in moving faster to market with superior biotherapeutics. We also use this expertise to strengthen our own drug pipeline. Albumedix is a global company and fully owned subsidiary of Novozymes A/S. Biopharmaceuticals, Drug Formulation, Drug Delivery, Recombinant Human Albumin, Recombinant Proteins, Genetic fusion, Chemical conjugation
keywords:N/A
N/A
Total Funding
108
Number of Employees
$21.7M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Albumedix News
Albumedix Ltd., a leader in Recombinant Human Albumin (rHA), specializing in the enablement of advanced therapies and biopharmaceuticals,...
NOTTINGHAM, England, April 14, 2022 /PRNewswire/ -- Valneva's inactivated COVID-19 vaccine, VLA2001, including Albumedix´ Recombinant Human...
Albumedix, Merck, Ventria (InVitria), NCPC, Oryzogen, HiMedia. Various factors are responsible for the market's growth trajectory,...
NOTTINGHAM, United Kingdom and KEELE, United Kingdom, April 28, 2021 /PRNewswire/ -- Albumedix Ltd. ('Albumedix'), an emerging leader in the enablement of advanced therapies and recognized global leader in recombinant human albumin (rHA) has today announced an extension to its research collabo ...
Other Companies in Belgravia
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $24.9M | 113 | N/A | N/A |
#2 | $28.5M | 157 | N/A | N/A |
#3 | $17.8M | 159 | -2% | N/A |
#4 | $20.4M | 185 | 21% | N/A |
#5 | $7.5M | 244 | 4% | N/A |